In the past 50 years, the survival rate for pancreatic cancer has only improved by 13%. This is not meaningful progress, and patients cannot rely on hope alone to live through this deadly disease. Pancreatic Cancer North America aims to disrupt the traditional approach to discovery in pancreatic cancer by bringing together multiple sectors, innovations, and novel methods to drive real change.

We’ve raised enough sympathy. It’s time to raise survival rates.